Surgery

Medicine and Dentistry

1. Breast Cancer 100%
2. Diseases 90%
3. Malignant Neoplasm 76%
4. Recurrent Disease 65%
5. Ovarian Cancer 65%
6. Neoplasm 64%
7. Chemotherapy 62%
8. Overall Survival 52%
9. Cancer 51%
10. Radiation Therapy 44%
11. Krukenberg Tumor 40%
12. Tumor 37%
13. Rectum Cancer 33%
14. Surgeon 31%
15. Melanoma 30%
16. Pleura Mesothelioma 28%
17. Retroperitoneal Lymph Node Dissection 27%
18. Photochemotherapy 26%
19. Oncology 25%
20. Chemoradiotherapy 21%
21. Surgery 20%
22. Mesothelioma 19%
23. Metastatic Carcinoma 19%
24. Neoadjuvant Therapy 19%
25. Adjuvant Therapy 19%
26. Gynecological Oncology 18%
27. Oncologist 18%
28. Mastectomy 17%
29. Pelvis 17%
30. Lymph Node 17%
31. Non Small Cell Lung Cancer 17%
32. Platinum 16%
33. Biopsy Technique 16%
34. Colorectal Carcinoma 15%
35. Cervical Cancer 15%
36. Sentinel Node 15%
37. Pancreas Cancer 14%
38. Intraductal Carcinoma 14%
39. Cisplatin 14%
40. Neoadjuvant Chemotherapy 14%
41. Liver Metastasis 14%
42. Hazard Ratio 13%
43. BRCA1 13%
44. Median Follow Up 13%
45. Cytoreductive Surgery 13%
46. Pancreas Adenocarcinoma 12%
47. Systemic Therapy 12%
48. Lung Cancer 11%
49. Morbidity 11%
50. Symptomatic Treatment 11%
51. Intraperitoneal Chemotherapy 11%
52. Cancer Surgery 11%
53. Carcinoma 11%
54. Disease Free Survival 11%
55. Bevacizumab 11%
56. Hormone Therapy 11%
57. Pneumonectomy 10%
58. Odds Ratio 10%
59. Primary Tumor 10%
60. Uterine Cancer 10%
61. Lung 10%
62. Adenocarcinoma 10%
63. Laparotomy 10%
64. Progression Free Survival 10%
65. Fluorouracil 10%
66. Phase II Trials 10%
67. Quadrantectomy 10%
68. Adjuvant Chemotherapy 9%
69. Colon Carcinoma 9%
70. Histology 9%
71. Retroperitoneal Sarcoma 9%
72. Medicare 9%
73. Infusion 9%
74. Folinic Acid 8%
75. Minimal Residual Disease 8%
76. Computer Assisted Tomography 8%
77. Clinical Trial 8%
78. Pleurectomy 8%
79. Prognostic Factor 8%
80. Abdominal Cancer 8%
81. Surgical Oncology 8%
82. Axillary Lymph Node 8%
83. Cancer Therapy 8%
84. Paclitaxel 8%
85. Pathologist 8%
86. Female Genital Tract Cancer 8%
87. Awareness 7%
88. Multivariate Analysis 7%
89. Hormone Receptor 7%
90. Sentinel Lymph Node 7%
91. Breast Reconstruction 7%
92. Bleeding 7%
93. Preoperative Radiotherapy 7%
94. Systematic Review 7%
95. Magnetic Resonance Imaging 7%
96. Adverse Event 7%
97. Quality of Life 7%
98. Incision 6%
99. Cancer Staging 6%
100. Lymph Duct 6%